In Situ Generated Gold Nanoparticle Hybrid Polymersomes for Water‐Soluble Chemotherapeutics: Inhibited Leakage and pH‐Responsive Intracellular Release
Source abstract
Abstract
Drug leakage in blood circulation is generally a serious concern to polymersomes when loading water‐soluble chemotherapeutics. If packing density of polymersome membrane is strengthened, premature drug release will be inhibited. Therefore, synthesis of a series of amphiphilic polyphosphazenes (PNPs) with 2‐diethylaminoethyl 4‐aminobenzoate (DEAB) as hydrophobic side groups and amino‐terminal poly(ethylene glycol) (NH2‐PEG2000) as hydrophilic chains is presented. By controlling the ratio of DEAB to NH2‐PEG2000, the optimal PNP‐3 is screened to ensure polymersome formation and high loading of doxorubicin hydrochloride (DOX·HCl). In situ generation method is initially employed to introduce gold nanoparticles (AuNPs) into vesicles' lamella, which can homogeneously distribute among DEAB sides via coordination interaction and act as inorganic cross‐linkers to aggregate polymer chains. Drug leakage of resultant AuNP hybrid PNP‐3 polymersome (IAuPNP‐3) at pH 7.4 is effectively alleviated and the systemic circulation time of DOX·HCl in mice is obviously prolonged. Besides, pH‐responsive drug release, due to the protonation of tertiary amine in DEAB, contributes to fast intracellular action. Based on the cooperation of these functions, DOX·HCl‐loaded IAuPNP‐3 finally achieves the highest in vivo antitumor efficacy compared with free DOX·HCl, drug‐loaded PNP, or EAuPNP prepared by prepreparation AuNPs method.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · Nanoparticle-Based Drug Delivery · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmaceutical Sciences Zhejiang University Hangzhou 310058 China
Ministry of Education (MOE) Key Laboratory of Macromolecular Synthesis and Functionalization Department of Polymer Science and Engineering Zhejiang University Hangzhou 310027 China
Funding
National Natural Science Foundation of China
References (36)
Show source-provided references
1. 10.1038/nature0786010.1038/nature07860 ↗
2. 10.1002/marc.20080047510.1002/marc.200800475 ↗
3. 10.1002/marc.20070088610.1002/marc.200700886 ↗
4. 10.1126/science.107599710.1126/science.1075997 ↗
5. 10.1016/j.jconrel.2003.12.02110.1016/j.jconrel.2003.12.021 ↗
6. 10.1002/mabi.20150029810.1002/mabi.201500298 ↗
7. 10.1002/anie.20140727210.1002/anie.201407272 ↗
8. 10.1002/anie.20150940110.1002/anie.201509401 ↗
9. 10.1039/C5NR08596A10.1039/C5NR08596A ↗
10. 10.1021/jp512531610.1021/jp5125316 ↗
11. 10.1021/am502822n10.1021/am502822n ↗
12. 10.1016/j.biomaterials.2010.06.02110.1016/j.biomaterials.2010.06.021 ↗
13. 10.1016/j.jconrel.2004.09.02610.1016/j.jconrel.2004.09.026 ↗
14. 10.1016/j.biomaterials.2009.12.04310.1016/j.biomaterials.2009.12.043 ↗
15. 10.1021/cr030063a10.1021/cr030063a ↗
16. 10.1016/0019-2791(71)90496-410.1016/0019-2791(71)90496-4 ↗
17. 10.1016/0092-8674(77)90109-X10.1016/0092-8674(77)90109-X ↗
18. 10.2217/17435889.2.5.68110.2217/17435889.2.5.681 ↗
19. 10.1038/sj.gt.330119210.1038/sj.gt.3301192 ↗
20. 10.1007/s11671-006-9015-710.1007/s11671-006-9015-7 ↗
21. 10.1021/am402574b10.1021/am402574b ↗
22. 10.1186/1472-6750-11-9810.1186/1472-6750-11-98 ↗
23. 10.1016/j.biortech.2009.03.01410.1016/j.biortech.2009.03.014 ↗
24. 10.1007/s10856-012-4590-x10.1007/s10856-012-4590-x ↗
25. 10.1166/jbn.2015.201010.1166/jbn.2015.2010 ↗
26. 10.1016/j.jconrel.2011.10.00510.1016/j.jconrel.2011.10.005 ↗
27. 10.1021/acs.biomac.5b0167610.1021/acs.biomac.5b01676 ↗
28. 10.1039/C4CC05946H10.1039/C4CC05946H ↗
29. 10.1016/j.colsurfb.2014.12.02110.1016/j.colsurfb.2014.12.021 ↗
30. 10.1002/mabi.20100033310.1002/mabi.201000333 ↗
31. 10.1039/C5DT02118A10.1039/C5DT02118A ↗
32. 10.1016/j.bbagen.2013.06.02510.1016/j.bbagen.2013.06.025 ↗
33. 10.1007/s11095-008-9797-710.1007/s11095-008-9797-7 ↗
34. 10.1016/j.jcis.2010.12.00410.1016/j.jcis.2010.12.004 ↗
35. 10.1039/C4RA09761K10.1039/C4RA09761K ↗
36. 10.1016/j.ijpharm.2013.07.07910.1016/j.ijpharm.2013.07.079 ↗